MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 81 filers reported holding MIRATI THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.12 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,048,067 | -28.8% | 28,189 | -13.2% | 0.00% | -33.3% |
| Q4 2022 | $1,472,122 | -69.8% | 32,490 | -55.3% | 0.01% | -77.8% |
| Q2 2022 | $4,882,000 | +272.7% | 72,722 | +356.2% | 0.03% | +440.0% |
| Q1 2022 | $1,310,000 | +310.7% | 15,940 | +785.1% | 0.01% | +400.0% |
| Q3 2021 | $319,000 | -80.9% | 1,801 | -82.6% | 0.00% | -83.3% |
| Q2 2021 | $1,669,000 | +50.2% | 10,330 | +104.2% | 0.01% | -25.0% |
| Q4 2020 | $1,111,000 | -20.8% | 5,058 | -53.5% | 0.01% | 0.0% |
| Q4 2019 | $1,402,000 | +34.8% | 10,879 | +7.7% | 0.01% | -20.0% |
| Q2 2019 | $1,040,000 | -82.9% | 10,100 | -87.8% | 0.01% | -84.4% |
| Q1 2019 | $6,078,000 | +443.2% | 82,924 | +214.4% | 0.06% | +392.3% |
| Q4 2018 | $1,119,000 | +156.7% | 26,379 | +85.8% | 0.01% | +85.7% |
| Q1 2018 | $436,000 | +78.0% | 14,200 | -32.3% | 0.01% | +40.0% |
| Q3 2017 | $245,000 | – | 20,975 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
| Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
| Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
| M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
| Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
| Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
| Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
| Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
| Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
| RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |